MedPath

Improving antithrombotic treatment in atrial fibrillatio

Conditions
Atrial Fibrillation, Prevention, Stroke
Registration Number
NL-OMON25098
Lead Sponsor
Academic Medical Center (AMC), Amsterdam
Brief Summary

/A

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

Patients: All patients with atrial fibrillation visisting one of the three selected hospitals in the Netherlands.

Physicians: All cardiologists working in one of the three selected hospitals in the Netherlands (Franciscus Ziekenhuis Roosendaal, Lievensberg Ziekenhuis Bergen op Zoom, and Beatrixziekenhuis Gornichem).

Exclusion Criteria

N/A

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
The proportion of patients with non-valvular atrial fibrillation whose anti-thrombotic treatment prescription is in accordance with the ESC guideline for atrial fibrillation.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath